日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner.

IL-1 以细胞类型特异性的方式阐明角鲨烯基佐剂的功效和反应原性。

Yoshioka Yuya, Nishinaka-Yoshioka Anri, Kobiyama Kouji, Hayashi Tomoya, Kidani Yujiro, Yanagida Yosuke, Kasahara Junpei, Tsujii Kenichiro, Asaoka Yoshiji, Kuroda Norikazu, Kugimiya Akira, Osawa Hiroaki, Yoshimura Akimasa, Onishi Motoyasu, Nakagawa Takayuki, Ishida Satoru, Omoto Shinya, Nagira Morio, Coban Cevayir, Ishii Ken J

Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study.

在 1/2 期初免-加强研究中,对 SARS-CoV-2 重组疫苗 S-268019-b 的免疫反应进行纵向分析

Fujitani Masaya, Lu Xiuyuan, Shinnakasu Ryo, Inoue Takeshi, Kidani Yujiro, Seki Naomi M, Ishida Satoru, Mitsuki Shungo, Ishihara Takeshi, Aoki Miwa, Suzuki Akio, Takahashi Koji, Takayama Masahiro, Ota Takeshi, Iwata Satoshi, Shibata Risa Yokokawa, Sonoyama Takuhiro, Ariyasu Mari, Kitano Ayumi, Terooatea Tommy, Kelly Villa Jordan, Yamashita Kazuo, Yamasaki Sho, Kurosaki Tomohiro, Omoto Shinya

Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

作者更正:SARS-CoV-2重组刺突蛋白疫苗S-268019-b在小鼠体内的免疫反应和保护效力

Homma, Tomoyuki; Nagata, Noriyo; Hashimoto, Masayuki; Iwata-Yoshikawa, Naoko; Seki, Naomi M; Shiwa-Sudo, Nozomi; Ainai, Akira; Dohi, Keiji; Nikaido, Eiji; Mukai, Akiko; Ukai, Yuuta; Nakagawa, Takayuki; Shimo, Yusuke; Maeda, Hiroki; Shirai, Seiki; Aoki, Miwa; Sonoyama, Takuhiro; Sato, Mamoru; Fumoto, Masataka; Nagira, Morio; Nakata, Fumihisa; Hashiguchi, Takao; Suzuki, Tadaki; Omoto, Shinya; Hasegawa, Hideki

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults

一项在日本成年人中开展的COVID-19重组疫苗S-268019-b与ChAdOx1 nCoV-19疫苗的3期随机对照试验

Iwata, Satoshi; Pollard, Andrew J; Tada, Yukio; Omoto, Shinya; Shibata, Risa Y; Igarashi, Kenji; Hasegawa, Takahiro; Ariyasu, Mari; Sonoyama, Takuhiro

The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir

PA/I38 替换和 PA 多态性对人畜共患甲型流感病毒巴洛沙韦敏感性的影响

Taniguchi, Keiichi; Noshi, Takeshi; Omoto, Shinya; Sato, Akihiko; Shishido, Takao; Matsuno, Keita; Okamatsu, Masatoshi; Krauss, Scott; Webby, Richard J; Sakoda, Yoshihiro; Kida, Hiroshi

A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component

A-910823 是一种基于角鲨烯的乳剂佐剂,它通过 α-生育酚成分诱导 T 滤泡辅助细胞和体液免疫反应。

Yoshioka, Yuya; Kobiyama, Kouji; Hayashi, Tomoya; Onishi, Motoyasu; Yanagida, Yosuke; Nakagawa, Takayuki; Hashimoto, Masayuki; Nishinaka, Anri; Hirose, Jun; Asaoka, Yoshiji; Tajiri, Minako; Hayata, Atsushi; Ishida, Satoru; Omoto, Shinya; Nagira, Morio; Ishii, Ken J

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults

一项针对啮齿动物的临床前研究以及一项针对日本成年人的 COVID-19 疫苗 S-268019-a 的 1/2 期随机、双盲、安慰剂对照、平行组研究的结果

Sonoyama, Takuhiro; Iwata, Satoshi; Shinkai, Masaharu; Iwata-Yoshikawa, Naoko; Shiwa-Sudo, Nozomi; Hemmi, Takuya; Ainai, Akira; Nagata, Noriyo; Matsunaga, Nobuaki; Tada, Yukio; Homma, Tomoyuki; Omoto, Shinya; Yokokawa Shibata, Risa; Igarashi, Kenji; Suzuki, Tadaki; Hasegawa, Hideki; Ariyasu, Mari

Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model

在雪貂模型中评估双重抗病毒药物耐药的人类流感病毒的适应性

Stannard, Harry L; Mifsud, Edin J; Wildum, Steffen; Brown, Sook Kwan; Koszalka, Paulina; Shishido, Takao; Kojima, Satoshi; Omoto, Shinya; Baba, Keiko; Kuhlbusch, Klaus; Hurt, Aeron C; Barr, Ian G

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.

SARS-CoV-2 重组刺突蛋白疫苗 S-268019-b 在小鼠中的免疫反应和保护效力

Homma Tomoyuki, Nagata Noriyo, Hashimoto Masayuki, Iwata-Yoshikawa Naoko, Seki Naomi M, Shiwa-Sudo Nozomi, Ainai Akira, Dohi Keiji, Nikaido Eiji, Mukai Akiko, Ukai Yuuta, Nakagawa Takayuki, Shimo Yusuke, Maeda Hiroki, Shirai Seiki, Aoki Miwa, Sonoyama Takuhiro, Sato Mamoru, Fumoto Masataka, Nagira Morio, Nakata Fumihisa, Hashiguchi Takao, Suzuki Tadaki, Omoto Shinya, Hasegawa Hideki

Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques

S-268019-b 是一种基于重组 S 蛋白和角鲨烯佐剂的疫苗,其同源和异源加强免疫可增强食蟹猴对 SARS-CoV-2 Omicron 亚型的中和广度。

Hashimoto, Masayuki; Aoe, Shinpei; Kawazu, Yusuke; Seki, Naomi M; Hashimoto, Kumi; Yoshihara, Ken; Homma, Tomoyuki; Sonoyama, Takuhiro; Omoto, Shinya